| Biological variation estimates for prostate specific antigen from the European Biological Variation Study; consequences for diagnosis and monitoring of prostate cancer, Carobene A, Guerra E, Locatelli M, Cucchiara V, Briganti A, Aarsand AK et al, 2018, Clin Chim Acta, 486, 185-91 | 7.1 | 46.2 | Males | Healthy (excl pregnant) | Serum |
| Intraindividual variations of total and percent free serum prostatic-specific antigen levels in patients with normal digital rectal examination, Morote J, Raventós CX, Lorente JA et al , 1999, Eur Urol, 36(2), 111-5 | 32.2 | | Males | Non-healthy (excl pregnant) | Serum |
| Intraindividual variation of PSA, free PSA and complexed PSA in a cohort of patients with prostate cancer managed with watchful observation, Bunting PS, DeBoer G, Choo R et al, 2002, Clin Biochem, 35, 471-5 | 19.3 | | Males | Non-healthy (excl pregnant) | Serum |
| Variation of free and total prostate-specific antigen levels: the effect on the percent free/total prostate-specific antigen, Nixon RG, Lilly JD, Liedtke RJ, Batjer JD, 1997, Arch Pathol Lab Med, 121(4), 385-91 | 13.0 | | Males | Non-healthy (excl pregnant) | Serum |
| Assessment of intra-individual variation in prostate-specific antigen levels in a biennal randomized prostate càncer screening program in Sweden, Bruun L, Becker Ch et al, 2005, Prostate, 65, 216-21 | 9.7 | | Males | Healthy (excl pregnant) | Serum |
| Assessment of intra-individual variation in prostate-specific antigen levels in a biennal randomized prostate càncer screening program in Sweden, Bruun L, Becker Ch et al, 2005, Prostate, 65, 216-21 | 7.5 | | Males | Healthy (excl pregnant) | Serum |
| Assessment of intra-individual variation in prostate-specific antigen levels in a biennal randomized prostate càncer screening program in Sweden, Bruun L, Becker Ch et al, 2005, Prostate, 65, 216-21 | 7.8 | | Males | Healthy (excl pregnant) | Serum |
| Day to day changes in free and total PSA: significance of biological variation, Nixon RG, Wener MH, Smith KM, Parson RE, Blase AB and Brawer MK, 1997, Prost Cancer and Prost diseas, 1, 90-6 | 12.0 | | Males | Non-healthy (excl pregnant) | Serum |
| Biological variation of total, free and percent free serumm protate specific antigen levels in screening volunteers, Ornstein DK, Smith DS et al, 1997, J Urol, 157, 2179-82 | 16.5 | | Males | Healthy (excl pregnant) | Serum |
| Biological variation of total, free and percent free serumm protate specific antigen levels in screening volunteers, Ornstein DK, Smith DS et al, 1997, J Urol, 157, 2179-82 | 16.5 | | Males | Healthy (excl pregnant) | Serum |
| Biological variation of total, free and percent free serumm protate specific antigen levels in screening volunteers, Ornstein DK, Smith DS et al, 1997, J Urol, 157, 2179-82 | 16.5 | | Males | Healthy (excl pregnant) | Serum |
| Intra-individual short-term variability of prostate-specific antigen and other kallikrein markers in a serial collection of blood from men under evaluation for prostate càncer, Christensson A, Bruun L, Björk T et al, 2011, BJU Int, 107, 1769-74 | 6.6 | | Males | Non-healthy (excl pregnant) | Serum |
| Intra-individual short-term variability of prostate-specific antigen and other kallikrein markers in a serial collection of blood from men under evaluation for prostate càncer, Christensson A, Bruun L, Björk T et al, 2011, BJU Int, 107, 1769-74 | 13.0 | | Males | Non-healthy (excl pregnant) | Serum |
